Editas Medicine(us:EDIT)
1.13
-2.59%
Updated on 2025-04-02
Open:1.15
Close:1.13
High:1.18
Low:1.12
Prev Close:1.16
Volume:2.13M
Turnover:2.44M
Turnover Ratio:2.56%
Shares:82.98M
MarketCap:93.76M
About Editas Medicine
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Name: Editas Medicine
Address: 11 Hurley Street
Employees: 265
Fiscar Year: 12-31
IPO Date: 2016-02-03
Website: http://www.editasmedicine.com
CIK: 1650664
View all SEC Filings
About
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Address:11 Hurley Street
Website:http://www.editasmedicine.com
Market Movers